LPL Financial’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIB
HAIM
YAG
WN
VF
MAWA
IWA
BCM
LPL Financial's TRIB Position: Q1 2026 in Review
LPL Financial increased its Trinity Biotech (TRIB) stake by 19% in Q1 2026, buying an estimated $1.73K and bringing the position to 15,036 shares worth $8.15K. The position accounts for ﹤0.01% of the portfolio, ranked #5934.
LPL Financial first reported a position in TRIB in Q2 2013 and has held it in 15 quarters since. The position peaked at $756K in Q2 2014. 23 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.
- LPL Financial held 15,036 shares of Trinity Biotech worth $8.15K as of Q1 2026.
- LPL Financial bought 2,351 Trinity Biotech shares in Q1 2026, an estimated $1.73K.
- Trinity Biotech made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5934 holding.
- LPL Financial first reported a position in Trinity Biotech in Q2 2013 and has held it in 15 quarters since.
- LPL Financial's Trinity Biotech position peaked at $756K in Q2 2014.
- 23 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.
Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.